Microbiota and COVID-19: A Novel Diagnostic Approach to Health and Diseases

D. Venkatesan, Sheetal Kaur, Mahalaxmi Iyer, Mohan Gomathi, Reza Rastmanesh, B. Vellingiri
{"title":"Microbiota and COVID-19: A Novel Diagnostic Approach to Health and Diseases","authors":"D. Venkatesan, Sheetal Kaur, Mahalaxmi Iyer, Mohan Gomathi, Reza Rastmanesh, B. Vellingiri","doi":"10.2174/0126667975291873240506111439","DOIUrl":null,"url":null,"abstract":"\n\nCoronavirus Disease 2019 (COVID-19) is a pandemic disease caused by a novel virus,\nSARS-CoV-2. COVID-19-infected people have high chance of altered microbiota in various regions\nof the human body, such as gut, oral, and respiratory pathways. In one such case, gastrointestinal\nsymptoms are mostly caused by disturbances in gut microbiota. The gut microbiota shows magnificent\nchanges in response to SARS-CoV-2 infection. The impairment of microbiota levels in humans\ncan lead to various neurological diseases. Here, in the present chapter, we have discussed the probable\nmechanistic approaches of SARS-CoV-2 infection altering microbiota present in the gut, oral,\nand respiratory regions, thereby leading to neurological diseases – Parkinson’s Disease (PD), Alzheimer’s\nDisease (AD) and depression mediated by inflammatory cytokines. We conclude that although\nthere are many underpinnings in the current knowledge on the mechanism of COVID-19-\nrelated microbiota disturbance, it can be speculated that these mechanistic approaches may be more\nthan just a coincidence. We advise conducting extensive epidemiologic investigations to create diagnostic\nand therapeutic options in the future.\n","PeriodicalId":10815,"journal":{"name":"Coronaviruses","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Coronaviruses","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0126667975291873240506111439","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Coronavirus Disease 2019 (COVID-19) is a pandemic disease caused by a novel virus, SARS-CoV-2. COVID-19-infected people have high chance of altered microbiota in various regions of the human body, such as gut, oral, and respiratory pathways. In one such case, gastrointestinal symptoms are mostly caused by disturbances in gut microbiota. The gut microbiota shows magnificent changes in response to SARS-CoV-2 infection. The impairment of microbiota levels in humans can lead to various neurological diseases. Here, in the present chapter, we have discussed the probable mechanistic approaches of SARS-CoV-2 infection altering microbiota present in the gut, oral, and respiratory regions, thereby leading to neurological diseases – Parkinson’s Disease (PD), Alzheimer’s Disease (AD) and depression mediated by inflammatory cytokines. We conclude that although there are many underpinnings in the current knowledge on the mechanism of COVID-19- related microbiota disturbance, it can be speculated that these mechanistic approaches may be more than just a coincidence. We advise conducting extensive epidemiologic investigations to create diagnostic and therapeutic options in the future.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
微生物群和 COVID-19:健康与疾病的新型诊断方法
冠状病毒病 2019(COVID-19)是一种由新型病毒 SARS-CoV-2 引起的流行病。COVID-19 感染者很有可能在人体的各个部位,如肠道、口腔和呼吸道,发生微生物群的改变。其中,胃肠道症状大多是由肠道微生物群紊乱引起的。SARS-CoV-2 感染后,肠道微生物群发生了巨大变化。人体微生物群水平的损害可导致各种神经系统疾病。在本章中,我们讨论了 SARS-CoV-2 感染改变肠道、口腔和呼吸道微生物群,从而导致由炎症细胞因子介导的神经系统疾病--帕金森病(PD)、阿尔茨海默病(AD)和抑郁症的可能机制。我们的结论是,尽管目前关于 COVID-19 相关微生物群紊乱机制的知识有许多基础,但可以推测这些机制方法可能不仅仅是巧合。我们建议开展广泛的流行病学调查,以便为未来的诊断和治疗提供选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
0
期刊最新文献
COVID-19 Vaccine Effectiveness on the Severity of Disease: A Case-control Study in Southeastern Iran Evaluation of Influenza Vaccination Coverage Among Healthcare Workers During the COVID-19 Pandemic and Analysis of Motivating and Hindering Factors Novel Coronavirus: An Overview of the History, Pathophysiology, Diagnosis, and Management of the Pandemic COVID-19 Catastrophe, with Special Emphasis on Herbal Treatment Alternatives Spectrum of Long COVID Symptoms and Management Approaches in Europe and Latin America Identification of Epitope Against Omicron Variant of SARS-CoV-2: In Silico Vaccine Design Approach
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1